Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

Detalhes bibliográficos
Main Authors: Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, Johan Wardell, Nils Witt, Yang Cao, Leif Bojö, Bo Nilsson, Johan Jendle
Formato: Artigo
Idioma:English
Publicado em: Frontiers Media S.A. 2018-02-01
Colecção:Frontiers in Endocrinology
Assuntos:
Acesso em linha:http://journal.frontiersin.org/article/10.3389/fendo.2018.00050/full
_version_ 1830517949976281088
author Thomas Nyström
Irene Santos-Pardo
Fredric Hedberg
Johan Wardell
Nils Witt
Yang Cao
Yang Cao
Leif Bojö
Bo Nilsson
Johan Jendle
author_facet Thomas Nyström
Irene Santos-Pardo
Fredric Hedberg
Johan Wardell
Nils Witt
Yang Cao
Yang Cao
Leif Bojö
Bo Nilsson
Johan Jendle
author_sort Thomas Nyström
collection DOAJ
first_indexed 2024-12-22T04:11:06Z
format Article
id doaj.art-d9c244e335cc47ac9a1cb98ddb51b3e1
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-22T04:11:06Z
publishDate 2018-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-d9c244e335cc47ac9a1cb98ddb51b3e12022-12-21T18:39:32ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922018-02-01910.3389/fendo.2018.00050358253Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group StudyThomas Nyström0Irene Santos-Pardo1Fredric Hedberg2Johan Wardell3Nils Witt4Yang Cao5Yang Cao6Leif Bojö7Bo Nilsson8Johan Jendle9Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, SwedenDepartment of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, SwedenDepartment of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, SwedenDepartment of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, SwedenDepartment of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, SwedenInstitution of Medical Sciences, Örebro University, Örebro, SwedenUnit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenCentral Hospital, Karlstad, SwedenCentral Hospital, Karlstad, SwedenClinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Swedenhttp://journal.frontiersin.org/article/10.3389/fendo.2018.00050/fulllongitudinal functional reserve indexliraglutidesubclinical heart failuretissue Doppler echocardiographytype 2 diabetes
spellingShingle Thomas Nyström
Irene Santos-Pardo
Fredric Hedberg
Johan Wardell
Nils Witt
Yang Cao
Yang Cao
Leif Bojö
Bo Nilsson
Johan Jendle
Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
Frontiers in Endocrinology
longitudinal functional reserve index
liraglutide
subclinical heart failure
tissue Doppler echocardiography
type 2 diabetes
title Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
title_full Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
title_fullStr Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
title_full_unstemmed Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
title_short Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
title_sort corrigendum effects on subclinical heart failure in type 2 diabetic subjects on liraglutide treatment vs glimepiride both in combination with metformin a randomized open parallel group study
topic longitudinal functional reserve index
liraglutide
subclinical heart failure
tissue Doppler echocardiography
type 2 diabetes
url http://journal.frontiersin.org/article/10.3389/fendo.2018.00050/full
work_keys_str_mv AT thomasnystrom corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy
AT irenesantospardo corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy
AT fredrichedberg corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy
AT johanwardell corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy
AT nilswitt corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy
AT yangcao corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy
AT yangcao corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy
AT leifbojo corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy
AT bonilsson corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy
AT johanjendle corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy